CEF1, Influenza Matrix Protein M1 (58-66) – 1 mg

Overview

The CEF1, Influenza Matrix Protein M1 (58-66) is an important peptide that serves as a restricted epitope, specifically for the HLA-A*02 molecule. This peptide plays a crucial role in immune response, particularly in CD8 T-cell activation, which is vital for fighting influenza infections. With the prevalence of HLA-A*02 expression in nearly half of the human population, understanding this peptide can enhance your research in immunology and vaccine development.

Key Features

• HLA-A*02-restricted epitope from influenza matrix protein (58-66)
• Induces an immunodominant CD8 T-cell response
• Useful for studies on influenza immune response
• High-quality synthesis for reliable results
• 1 mg of peptide for various experimental applications

Specifications

FAQ

What is the significance of the CEF1 peptide?

The CEF1 peptide is significant in immunological research as it is recognized by CD8 T-cells, providing insights into the immune response against influenza virus. This can be instrumental in developing effective vaccines.

How can I use the CEF1 peptide in my research?

You can utilize the CEF1 peptide in various assays focused on T-cell activation and immune response studies. It’s particularly useful for examining how HLA-A*02-restricted responses work.

Is this peptide suitable for in vivo studies?

This peptide is primarily designed for in vitro studies. For in vivo application, further validation and safety assessments would be necessary.

Explore our extensive range of peptides to find complementary products that can further your research. Enhance your experimentation with proven substrates like PKG Substrate or specialized peptides such as Autocamtide-2. Elevate your analysis with high-quality products that support reproducible results.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled